GET THE APP

..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Anil Wali

Anil Wali

Anil Wali, PhD
Program Director
National Cancer Institute, USA

Biography

Anil Wali  is a Program Director in the Diversity Training Branch for the Center to Reduce Cancer Health Disparities. He provides technical and scientific expertise and grants program administration guidance to trainees and early stage investigators. Dr. Wali joined CRCHD in 2009 from Wayne State University, Detroit Medical Center and NCI designated Comprehensive Cancer Center Barbara Ann Karmanos Cancer Institute where he served as Associate Professor in the Departments of Surgery and Pathology. Dr. Wali also served as Principal Investigator on a Veterans Administration Merit Review award funded project on the Role of Ubiquitin-Proteasome Pathway in Mesothelioma Carcinogenesis. Dr. Wali conducted NCI Clinical trial on asbestos exposed patient populations to determine their risk for developing Lung Cancer and Mesothelioma using high throughput Genomics and Proteomics technologies. Dr. Wali received his B.S. and M.S. degrees from the University of Kashmir, in Srinagar, India. He earned his Ph.D. at the Postgraduate Institute in Chandigarh, India. Dr. Wali completed postdoctoral training at the Institute for Environmental Medicine at the University of Pennsylvania at the FELS Institute for Cancer Research at Temple University, Philadelphia, PA and in the Department of Pathology at Thomas Jefferson University, Philadelphia, PA.

Research Interest

Lung Cancer, Genomics and Proteomics.

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward